Evidence map›Paper›PMID 39534570›Full record

ArticleGenes & diseases2025

IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an m

Jiadai Xu, Yawen Wang, Liang Ren, Panpan Li, Peng Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes & diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Emerging roles of RNA mInternational journal of oncology · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiadai XuDepartment of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
Yawen WangDepartment of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
Liang RenDepartment of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
Panpan LiDepartment of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
Peng LiuDepartment of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200030, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple myeloma (MM) patients with chromosome 1q gain (1q+) are clinically and biologically heterogeneous. The underlying molecular mechanisms are still under investigation, while the identification of targets for effective therapy of this subgroup of MM patients is urgently needed. We aimed to investigate the clinical significance and the regulatory mechanisms of insulin-like growth factor 2 messenger RNA (mRNA) binding protein 1 (IGF2BP1), a N6-methyladenosine (m

Indexed as

CDC5LChromosome 1q gainIGF2BP1Multiple myelomaN6-methyladenosine

Identifiers

PMID39534570
PMCPMC11554607

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.